Sign in

CIK 0001933414

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
841966887
Phone
+1 888-378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-13 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,018 40,138
2024-05-13 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −6,348 196,706
2024-05-09 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +100 $1.08 $108 67,097
2024-05-09 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −100 $15.00 $2K 66,997
2024-05-09 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −100 203,054
2024-04-12 Rodman David Malcom Chief Medical Officer Option exercise +6,349 $1.08 $7K 66,997
2024-04-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −6,349 203,154
2024-04-11 Rodman David Malcom Chief Medical Officer Option exercise +5,017 $0.54 $3K 60,648
2024-04-11 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,017 45,156
2024-03-12 Rodman David Malcom Chief Medical Officer Option exercise +6,348 $1.08 $7K 55,631
2024-03-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −6,348 209,503
2024-03-11 Rodman David Malcom Chief Medical Officer Option exercise +5,017 $0.54 $3K 49,283
2024-03-11 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option −5,017 50,173
2024-02-13 Rodman David Malcom Chief Medical Officer Grant or award · Stock Option +200,000 200,000
2024-02-13 Levy Adam Scott CFO and Secretary Grant or award · Stock Option +200,000 200,000
2024-02-13 Congleton Jon Chief Executive Officer Grant or award · Stock Option +425,000 425,000
2024-02-12 AKKARAJU SRINIVAS Director Grant or award +555,555 $13.50 $7.5M 5,074,916
2024-02-12 Samsara BioCapital GP, LLC 10% owner Purchase +555,555 $13.50 $7.5M 5,074,916
2024-02-12 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +1,672,508 $13.50 $22.6M 2,983,755
2024-02-12 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Pre-Funded Warrants (Right to Buy) +549,755 $13.50 $7.4M 549,755

Page 19 of 23 · 446 trades